Intervention
In the previous (2010-2016) cohort, doxorubicin was used in the
induction therapy (6 weeks). It was dropped in the current cohort
(2017-2020) from the induction phase once the L-asparaginase supply was
consistent. The patients received a three-drug induction (vincristine,
prednisone, and L-asparaginase) lasting six weeks. Additionally,
patients who did not have health insurance (NHIF) were supported to
enroll and transport assistance for needy parents through collaboration
with philanthropic organizations and continuous parental counseling and
support groups. The social work department facilitated this. Supportive
care included better availability and early initiation of antibiotics
during episodes of febrile neutropenia and enhanced availability of
blood products.